Filters: Author is Boers,M. [Clear All Filters]
How to ascertain drug safety in the context of benefit. Controversies and concerns. Journal of Rheumatology. 2009;36(9):2114-21. Abstract
Health outcomes assessment. In: Green's rheumatology.; 2006.
Minimal disease activity for rheumatoid arthritis: a preliminary definition. Journal of Rheumatology. 2005;32(10):2016-24. Abstract
Many faces of the minimal clinically important difference (MCID): a literature review and directions for future research. Current Opinion in Rheumatology. 2002;14(2):109-14. Abstract
Looking for important change/differences in studies of responsiveness. OMERACT MCID Working Group. Outcome Measures in Rheumatology. Minimal Clinically Important Difference. Journal of Rheumatology. 2001;28(2):400-5. Abstract
Minimal clinically important differences: review of methods. Journal of Rheumatology. 2001;28(2):406-12. Abstract

]